Pharmacy Times
FEBRUARY 19, 2024
The full scope of pharmacy practice offers a transformative approach to health care delivery, promising improved patient outcomes, greater access to care, and efficient utilization of health care resources.
Drug Store News
FEBRUARY 21, 2024
Recent data from YouGov Profiles reveals that nearly half of Americans (47%) buy OTC drugs as required rather than stocking up, followed by 39% who keep a stock of medications but buy others when necessary.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
FEBRUARY 21, 2024
How much longer can independent pharmacists survive with the current method of reimbursement?
STAT
FEBRUARY 23, 2024
Hospitals, pharmacies, and other health care providers are getting stuck in an insurance processing logjam after UnitedHealth Group disclosed a cyberattack within a recently acquired subsidiary that serves as a central hub for payments across the industry. The cyberattack and subsequent system outage within UnitedHealth’s Change Healthcare has caught the attention of federal law enforcement agencies.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
FEBRUARY 19, 2024
California's Stop Dangerous Pharmacies Act aims to improve patient safety by establishing new pharmacy staffing regulations and a medication error reporting system, arising from understaffed conditions.
Fierce Healthcare
FEBRUARY 22, 2024
Investors continue to pour money into generative AI startups and Abridge is riding this wave as it rapidly scales its technology across U.S. health systems. | Along with the funding round, Abridge also announced an enterprise agreement with Connecticut-based Yale New Haven Health System to give thousands of clinicians access to its AI-powered clinical documentation technology.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
FEBRUARY 22, 2024
A Florida state policy set amid a measles outbreak in Broward County has vaccination proponents aghast, with many saying it leaves unvaccinated children especially vulnerable to the highly contagious disease. In a letter dated Tuesday about an outbreak at Manatee Bay Elementary School in Weston, located northwest of Miami and west of Fort Lauderdale, the state’s surgeon general, Joseph Ladapo, said that while it is normal policy to tell unvaccinated children to stay home during an outbrea
Pharmacy Times
FEBRUARY 22, 2024
Patients and other stakeholders need to be able to compare pharmacies based on standardized, transparent metrics with a measurement system to make informed decisions.
Fierce Healthcare
FEBRUARY 22, 2024
Change Healthcare is mitigating a "cybersecurity issue" that began Wednesday, and details remain scant. | Change Healthcare is mitigating a "cybersecurity issue" that began Wednesday, and details remain scant.
Drug Topics
FEBRUARY 23, 2024
During a session at the Outcomes 2024 SYNC National Conference, Pacience Edwards, PharmD, manager of compliance at Outcomes, discussed the impacts that advancements in technology have had on pharmacy.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
FEBRUARY 22, 2024
When a psychology professor in Michigan looked through his data on interpersonal conflict a decade ago, he discovered something unexpected. The study , which examined differences across cultures and age groups, seemed to show Americans got wiser as they got older. Richard Nisbett was used to research showing poorer mental skills among elderly adults, but his work found they were better at recognizing multiple perspectives, encouraging compromise, and acknowledging the limits of their own knowled
pharmaphorum
FEBRUARY 23, 2024
Explore the opportunities and challenges facing rare disease therapies developers, including the impact of Rare Disease Day, FDA regulations, and cutting-edge technologies like CRISPR gene therapy.
Pharmacy Times
FEBRUARY 23, 2024
The evolution of pharmacy, as a practice and profession, is unique in that its evolution has quickened exponentially in just the past 20 years.
Drug Topics
FEBRUARY 22, 2024
On January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
FEBRUARY 22, 2024
Imagine having 15 miscarriages. Maybe you can shrug off the first one or two and keep trying to have children, to create a family. But soon every positive pregnancy test brings a sense of dread, of sad inevitability. Your body becomes your enemy.
Fierce Healthcare
FEBRUARY 22, 2024
Fourteen organizations representing providers, payers, consumer technology companies and employers are teaming up to cut through the noise and raise higher standards for finding digital health | Fourteen organizations representing providers, payers, consumer technology companies and employers are teaming up to cut through the noise and raise higher standards for finding digital health solutions that work and are worth the investment.
Fierce Pharma
FEBRUARY 23, 2024
A narrow miss in a confirmatory trial has | Along with host of other positive recommendations, European drug regulators rendered a positive opinion on Travere's Filspari for full approval in Berger’s disease.
Drug Topics
FEBRUARY 23, 2024
With over 3% of the world’s population affected by chronic hepatitis B, TherVacB has the potential to address a critical unmet need for a cure.
STAT
FEBRUARY 21, 2024
Alison Sbrana was in the belly of an opera when her life changed. Down in the pit, surrounded by fellow orchestra members, she’d been straining to play her flute for half the show. As performers overhead enveloped the audience in arias, Sbrana felt like the Hulk was pulling on the tendons in the right side of her neck. “I begged anybody for meds at intermission,” she said.
Pharmacy Times
FEBRUARY 22, 2024
Currently, the safety and efficacy of linvoseltamab in adult patients with relapsed or refractory multiple myeloma is being compared to elotuzumab, pomalidomide, and dexamethasone in a phase 3 clinical trial.
Fierce Pharma
FEBRUARY 23, 2024
Even Alexander Hardy, the former Genentech leader who managed the blockbuster hemophilia drug Hemlibra, can’t immediately bend the laggard launch trajectory of BioMarin’s gene therapy Roctavian.
Drug Topics
FEBRUARY 21, 2024
The novel drug elranatamab-bcmm (Elrexfio) received accelerated FDA approval on August 14, 2023, for treating adults with relapsed or refractory multiple myeloma.
STAT
FEBRUARY 21, 2024
SAN FRANCISCO — Outside, the August sun wasn’t yet visible through the thick folds of fog blanketing the San Francisco skyline. Its warmth did not reach the operating room tucked into the sprawling Parnassus Heights hospital complex. In there, the light was all cold and blue fluorescence washing over the sea of scrub caps huddled around an anesthetized young woman on a gurney.
pharmaphorum
FEBRUARY 21, 2024
Clinical research involves trial and error as part of the drug development process. Learn more about how to optimise drug trials and the important role of participants in clinical research.
Fierce Healthcare
FEBRUARY 21, 2024
Given the impact that social factors have on overall health, employers can better manage costs and outcomes by embracing deeper, population-level data analysis, according to a new white paper. | Given the impact that social factors have on overall health, employers can better manage costs and outcomes by embracing deeper, population-level data analysis, according to a new white paper.
Drug Topics
FEBRUARY 23, 2024
Manufacturer ARS Pharma will submit the data as part of a response to a CRL received in 2023.
STAT
FEBRUARY 21, 2024
People with autoimmune disorders don’t usually get to talk about a cure. There’s symptom management, hopeful periods of remission often followed by relapses, but rarely a lasting fix for the way their immune system attacks healthy cells. If the immune system is an army, then those with conditions like lupus, multiple sclerosis, or rheumatoid arthritis are often fighting a never-ending war of friendly fire.
Fierce Pharma
FEBRUARY 20, 2024
After laying out plans to absorb a pair of production subsidiaries in October, Japan’s Daiichi Sankyo is doubling down on its quest to dominate the red-hot antibody-drug conjugate (ADC) field. | Aiming to beef up development and manufacturing of antibody-drug conjugates, Daiichi Sankyo is plugging roughly €1 billion ($1.08 billion) into an expansion of its production facility in Pfaffenhofen an der Ilm, Germany.
Pharmacy Times
FEBRUARY 19, 2024
Matthew Pianko, MD, outlines the logistical considerations involved when implementing bispecific antibodies for the treatment of multiple myeloma, including the roles of the project champion and other stakeholders as part of a multidisciplinary team.
Drug Topics
FEBRUARY 19, 2024
After myocardial infarction, all-cause mortality was the most frequent event, followed by heart failure, renal failure, and atrial fibrillation.
STAT
FEBRUARY 20, 2024
Groundbreaking research more than a decade ago showed that almost one-fifth of people enrolled in Medicare were being readmitted within 30 days after being discharged from the hospital, harming patients and increasing costs. That study led to a sea change in health care. The government started closely monitoring readmission rates and imposing fines on hospitals with high rates.
pharmaphorum
FEBRUARY 19, 2024
Fast approaching the end of its patent life, Roche and Novartis’ Xolair is going out with a bang, picking up a new approval as the first and only drug therapy for people with food allergies in the US.
Pharmacy Times
FEBRUARY 22, 2024
The practice could become routine if parents promote morning vegetable consumption while the children are still in a developmental stage of life.
Drug Topics
FEBRUARY 21, 2024
Offering services such as point-of-care testing and bundled products marketed as recovery kits can increase customer loyalty.
Expert insights. Personalized for you.
139 
Let's personalize your content